For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

Building a Resilient Brain To Prevent Alzheimer’s Disease

The bioenergetic changes that occur with the aging brain are at the heart of new research.

A new research study led by Fei Yin, PhD, and funded by a $1.1 million grant from the National Institutes of Health, will help determine the role of an Alzheimer’s risk-factor gene in regulating the brain energy production system.

https://healthsciences.arizona.edu/newsroom/news-releases/2021/researchers-focus-building-resilient-brain-prevent-alzheimers-disease

 

 

 

 

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2021 Center for Innovation Brain Science. University of Arizona Health Sciences.